YU99802A - Polimorfni oblici/hidrati n-(4-(3-hloro-4-fluoro-fenilamino) -7-(3-morfolin-4-ilpropoksi)-hinolazin-6-il)-akrilamid dihidrohlorida - Google Patents

Polimorfni oblici/hidrati n-(4-(3-hloro-4-fluoro-fenilamino) -7-(3-morfolin-4-ilpropoksi)-hinolazin-6-il)-akrilamid dihidrohlorida

Info

Publication number
YU99802A
YU99802A YU99802A YUP99802A YU99802A YU 99802 A YU99802 A YU 99802A YU 99802 A YU99802 A YU 99802A YU P99802 A YUP99802 A YU P99802A YU 99802 A YU99802 A YU 99802A
Authority
YU
Yugoslavia
Prior art keywords
ylpropoxy
quinazolin
morpholin
hydrates
chloro
Prior art date
Application number
YU99802A
Other languages
English (en)
Inventor
Hubert Barth
Klaus Steiner
Simon Schneider
Dietmar Huls
Andreas Muhlenfeld
Manfred Westermayer
Original Assignee
Godecke Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Godecke Gmbh. filed Critical Godecke Gmbh.
Publication of YU99802A publication Critical patent/YU99802A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Opisani su polimorfni oblici/hidrati N-[2-(3-hloro-4-fluorofenilamino)-7-(3-morfolin-4-il-propoksi)hinazolin-6-il]-akrilamid dihidrohlorid, postupci njihovog dobijanja kao i upotreba za dobijanje lekova sa ireverzibilnim inhibirajućim dejstvom na tirozin kinazu.[There are described polymorphic forms/hydrates of N-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6- yl]-acrylamide dihydrochloride, processes for their preparation, as well as the use of the same for the preparation of medicaments with irreversible tyrosine kinase inhibiting action.
YU99802A 2000-06-30 2001-06-15 Polimorfni oblici/hidrati n-(4-(3-hloro-4-fluoro-fenilamino) -7-(3-morfolin-4-ilpropoksi)-hinolazin-6-il)-akrilamid dihidrohlorida YU99802A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10031971A DE10031971A1 (de) 2000-06-30 2000-06-30 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung

Publications (1)

Publication Number Publication Date
YU99802A true YU99802A (sh) 2005-11-28

Family

ID=7647397

Family Applications (1)

Application Number Title Priority Date Filing Date
YU99802A YU99802A (sh) 2000-06-30 2001-06-15 Polimorfni oblici/hidrati n-(4-(3-hloro-4-fluoro-fenilamino) -7-(3-morfolin-4-ilpropoksi)-hinolazin-6-il)-akrilamid dihidrohlorida

Country Status (39)

Country Link
US (1) US20040034022A1 (sh)
EP (1) EP1299363A1 (sh)
JP (1) JP2004501902A (sh)
KR (1) KR20030014403A (sh)
CN (1) CN1438994A (sh)
AP (1) AP2002002694A0 (sh)
AR (1) AR031854A1 (sh)
AU (1) AU2001283861A1 (sh)
BG (1) BG107352A (sh)
BR (1) BR0112082A (sh)
CA (1) CA2412535A1 (sh)
CZ (1) CZ20024037A3 (sh)
DE (1) DE10031971A1 (sh)
DZ (1) DZ3342A1 (sh)
EA (1) EA005294B1 (sh)
EC (1) ECSP024413A (sh)
EE (1) EE200200714A (sh)
GT (1) GT200100124A (sh)
HN (1) HN2001000134A (sh)
HR (1) HRP20021019A2 (sh)
HU (1) HUP0300900A3 (sh)
IL (1) IL152419A0 (sh)
IS (1) IS6596A (sh)
MA (1) MA26924A1 (sh)
MX (1) MXPA03000101A (sh)
NO (1) NO20026193L (sh)
NZ (1) NZ522001A (sh)
OA (1) OA12301A (sh)
PA (1) PA8520801A1 (sh)
PE (1) PE20020116A1 (sh)
PL (1) PL365127A1 (sh)
SK (1) SK17642002A3 (sh)
SV (1) SV2002000517A (sh)
TN (1) TNSN01090A1 (sh)
UA (1) UA73588C2 (sh)
UY (1) UY26803A1 (sh)
WO (1) WO2002000630A1 (sh)
YU (1) YU99802A (sh)
ZA (1) ZA200209717B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005239878B9 (en) * 2004-05-06 2010-01-07 Warner-Lambert Company Llc 4-phenylamino-quinazolin-6-yl-amides
DE102006000122A1 (de) * 2006-03-17 2007-09-20 Aug. Winkhaus Gmbh & Co. Kg Schlüssel für einen Schließzylinder und Schließzylinder für einen solchen Schlüssel
JP6674027B2 (ja) * 2015-12-25 2020-04-01 シュアンチュー ファーマ カンパニー，リミティド キナゾリン誘導体の結晶及びその調製方法
JP6717947B2 (ja) * 2015-12-25 2020-07-08 シュアンチュー ファーマ カンパニー，リミティド キナゾリン誘導体の結晶及びその調製方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL190489B1 (pl) * 1996-04-12 2005-12-30 Warner Lambert Co Nieodwracalne inhibitory kinaz tyrozyny, kompozycja farmaceutyczna je zawierająca i ich zastosowanie
EE200100271A (et) * 1998-11-19 2002-10-15 Warner-Lambert Company N-[4-(3-kloro-4-fluorofenüülamino)-7-(3-morfoliin-4-üülpropoksü)kinasoliin-6-üül]ak rüülamiid kui türosiinkinaaside pöördumatu inhibiitor

Also Published As

Publication number Publication date
TNSN01090A1 (fr) 2005-11-10
NO20026193D0 (no) 2002-12-23
IL152419A0 (en) 2003-05-29
US20040034022A1 (en) 2004-02-19
AR031854A1 (es) 2003-10-08
AU2001283861A1 (en) 2002-01-08
HRP20021019A2 (en) 2004-02-29
NO20026193L (no) 2003-01-27
DZ3342A1 (fr) 2002-01-03
PL365127A1 (en) 2004-12-27
CN1438994A (zh) 2003-08-27
CA2412535A1 (en) 2002-01-03
PE20020116A1 (es) 2002-02-27
BG107352A (bg) 2003-07-31
HUP0300900A3 (en) 2004-01-28
UA73588C2 (en) 2005-08-15
UY26803A1 (es) 2002-01-31
GT200100124A (es) 2002-06-27
KR20030014403A (ko) 2003-02-17
EP1299363A1 (en) 2003-04-09
WO2002000630A1 (en) 2002-01-03
PA8520801A1 (es) 2003-06-30
AP2002002694A0 (en) 2002-12-31
BR0112082A (pt) 2003-05-06
HUP0300900A2 (hu) 2003-10-28
CZ20024037A3 (cs) 2004-01-14
IS6596A (is) 2002-10-28
OA12301A (en) 2003-11-10
HN2001000134A (es) 2001-09-11
DE10031971A1 (de) 2002-01-10
JP2004501902A (ja) 2004-01-22
SV2002000517A (es) 2002-07-03
EE200200714A (et) 2004-08-16
MA26924A1 (fr) 2004-12-20
NZ522001A (en) 2004-07-30
MXPA03000101A (es) 2004-09-13
SK17642002A3 (sk) 2004-05-04
ZA200209717B (en) 2003-12-01
ECSP024413A (es) 2003-03-31
EA005294B1 (ru) 2004-12-30
EA200300094A1 (ru) 2003-04-24

Similar Documents

Publication Publication Date Title
DK1131304T3 (da) N-[4-(3-chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamid, en irreversibel inhibitor for tyrosin-kinaser
MXPA05007831A (es) Preparacion de quinazolinas substituidas.
IL174261A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
PL373300A1 (en) Novel tyrosine kinase inhibitors
HK1049663A1 (en) Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4- quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
ATE419253T1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
GB0124933D0 (en) Chemical compounds
HK1079195A1 (en) Quinazoline derivatives as src tyrosine kinase inhibitors
UA85394C2 (ru) Замещенные хинолины в качестве ингибиторов ферментов протеинтирозиновых киназ
WO2004013091A3 (en) 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
YU99802A (sh) Polimorfni oblici/hidrati n-(4-(3-hloro-4-fluoro-fenilamino) -7-(3-morfolin-4-ilpropoksi)-hinolazin-6-il)-akrilamid dihidrohlorida
SI1131304T1 (en) N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl)-acrylamide, an irreversible inhibitor of tyrosine kinases
AU2002251636A1 (en) Novel use of tyrosine kinase inhibitor